A detailed history of Virginia Retirement Systems Et Al transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Virginia Retirement Systems Et Al holds 1,342,695 shares of GILD stock, worth $124 Million. This represents 1.0% of its overall portfolio holdings.

Number of Shares
1,342,695
Previous 1,263,095 6.3%
Holding current value
$124 Million
Previous $97.3 Million 3.36%
% of portfolio
1.0%
Previous 0.94%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Jan 02, 2024

BUY
$73.94 - $80.67 $5.89 Million - $6.42 Million
79,600 Added 6.3%
1,342,695 $101 Million
Q2 2023

Aug 22, 2023

BUY
$76.01 - $86.7 $2.93 Million - $3.35 Million
38,600 Added 3.15%
1,263,095 $97.3 Million
Q1 2023

Jul 11, 2023

BUY
$77.31 - $88.08 $25.6 Million - $29.2 Million
331,195 Added 37.08%
1,224,495 $102 Million
Q4 2022

May 17, 2023

BUY
$62.32 - $89.47 $13.3 Million - $19.1 Million
213,200 Added 31.35%
893,300 $76.7 Billion
Q3 2022

May 16, 2023

BUY
$59.54 - $68.01 $40.5 Million - $46.3 Million
680,100 New
680,100 $42 Billion
Q2 2021

Aug 13, 2021

SELL
$63.47 - $69.35 $6.94 Million - $7.59 Million
-109,400 Closed
0 $0
Q1 2021

Apr 30, 2021

BUY
$60.0 - $68.46 $6.56 Million - $7.49 Million
109,400 New
109,400 $7.07 Million
Q4 2020

Feb 16, 2021

SELL
$56.65 - $64.55 $12.6 Million - $14.4 Million
-223,200 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$62.1 - $78.08 $6.41 Million - $8.07 Million
-103,300 Reduced 31.64%
223,200 $14.1 Million
Q2 2020

Aug 12, 2020

BUY
$72.34 - $84.0 $18.8 Million - $21.8 Million
260,000 Added 390.98%
326,500 $25.1 Million
Q1 2020

May 12, 2020

BUY
$62.63 - $80.22 $4.16 Million - $5.33 Million
66,500 New
66,500 $4.97 Million
Q4 2019

Jan 27, 2020

SELL
$61.62 - $67.78 $6.47 Million - $7.12 Million
-105,000 Closed
0 $0
Q3 2019

Oct 22, 2019

SELL
$62.51 - $69.0 $1.66 Million - $1.84 Million
-26,600 Reduced 20.21%
105,000 $6.66 Million
Q2 2019

Jul 26, 2019

BUY
$61.87 - $69.38 $3.22 Million - $3.61 Million
52,000 Added 65.33%
131,600 $8.89 Million
Q1 2019

Apr 25, 2019

SELL
$62.53 - $70.05 $6.05 Million - $6.78 Million
-96,800 Reduced 54.88%
79,600 $5.18 Million
Q4 2018

Feb 07, 2019

BUY
$60.54 - $79.0 $6.88 Million - $8.98 Million
113,700 Added 181.34%
176,400 $11 Million
Q2 2018

Aug 03, 2018

BUY
$64.88 - $75.68 $4.07 Million - $4.75 Million
62,700 New
62,700 $4.44 Million

Others Institutions Holding GILD

About GILEAD SCIENCES, INC.


  • Ticker GILD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,253,369,984
  • Market Cap $116B
  • Description
  • Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...
More about GILD
Track This Portfolio

Track Virginia Retirement Systems Et Al Portfolio

Follow Virginia Retirement Systems Et Al and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Virginia Retirement Systems Et Al, based on Form 13F filings with the SEC.

News

Stay updated on Virginia Retirement Systems Et Al with notifications on news.